glp-1 therapy protein intake optimization research Impact of GLP- 1 Receptor Agonist in Patients High Risk for Sarcopenia | Current Nutrition Reports GLP-1 Drugs and the Importance

Discover ingredient solutions for sugar reduction, fiber enrichment and plant-based proteins to meet GLP-1-driven consumer demands

New research featuring DCRIs Stephen Greene assessed the effects of GLP-1RAs on heart failure hospitalization and cardiovascular death across populations with varying type and number of CKM comorbidity, finding the treatment helped reduce deaths

For all outcomes, we extracted data for the modified intention-to-treat population, defined as all randomly assigned participants who received a least one dose of the study drug

Thankfully, the FOCUS Trial was initiated in 2019 and is expected to be completed in 2027

#drbenng #endocrinologist #endocrinedoctor #hormonedoctor #medicaldoctor #doctorexplains #doctortalks #healthcareeducation #healthtips #medicaladvice #patienteducation #healthexplained #doctoranswers #glp1 | Arden Endocrinology Specialist Clinic